Research Event Announcement: Wave Life Sciences to Host Virtual Research Day on October 29th and Attend Upcoming Financial Meetings
Wave Life Sciences Ltd., a clinical-stage biotechnology company based in Cambridge, MA, is gearing up to present its groundbreaking RNA medicines at several upcoming investor conferences. The company, whose shares trade on Nasdaq under the ticker symbol WVE, is renowned for its innovative platform, PRISM®, which combines multiple modalities, chemistry innovation, and deep insights in human genetics.
The Wave Life Sciences management team, led by CEO Paul Bolno, MD, MBA, will participate in a series of fireside chats and panel discussions. On September 24, 2025, Dr. Erik Ingelsson, the Chief Scientific Officer, will take part in an analyst-led fireside chat at the Bernstein 2 Annual Healthcare Forum at 2:50 p.m. ET. On September 30, 2025, at 1:00 p.m. ET, Paul Bolno himself will participate in the Stifel Virtual Cardiometabolic Forum.
Moreover, on October 21, 2025, at 1:00 p.m. ET, Paul Bolno will join a panel discussing RNA editing therapeutics at Chardan's 9th Annual Genetic Medicines Conference.
In addition to these events, Wave Life Sciences will host its own virtual Research Day on October 29, 2025, at 10:00 a.m. ET. More details about this event will be provided at a later date.
The company's toolkit of RNA-targeting modalities includes editing, splicing, RNA interference, and antisense silencing. This diversified pipeline includes clinical programs in alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
For those interested in staying updated on Wave Life Sciences, the company can be followed on X (formerly Twitter) and LinkedIn. Kate Rausch serves as the VP of Corporate Affairs and Investor Relations, while James Salierno is the Director of Investor Relations. For more information on Wave Life Sciences' science, pipeline, and people, visit their website at https://www.wavelifesciences.com.
Wave Life Sciences is also scheduled to participate in analyst discussions at the Jefferies 2025 Healthcare Conference, J.P. Morgan 2025 Healthcare Conference, and BMO Capital Markets 2025 Biotech Conference. Specific participant details and exact topics have not been publicly disclosed yet.
Live webcasts and replays of Wave Life Sciences' presentations can be accessed on their Investor Events page: https://ir.wavelifesciences.com/events-publications/events. Katie Sullivan serves as the Senior Director of Corporate Communications at Wave Life Sciences.
Read also:
- Musk threatens Apple with litigation amidst increasing conflict surrounding Altman's OpenAI endeavor
- E-mobility continues its progress after a decade since the scandal, staying on course
- The Commission deems the assistance program to be in agreement with the domestic market regulations.
- Innovative Garments and Accessories Producing Energy: Exploring Unconventional Sources for Renewable Power
